Cutaneous coagulation clues for COVID-19; plus, academic derm in a pandemic

Thursday, August 13, 2020

COVID-19 has had profound effects on the financial stability of academic institutions, resident training, and patient care. Candrice Heath, MD (@DrCandriceHeath) talks to Erin Boh, MD, and Dirk Elston, MD, about emergency response plans in the academic setting as well as how institutions have been using teledermatology and managing resident education.

“Our institution is doing quite well because we’ve actually jumped headlong and feetfirst into COVID research. . . . Our research dollars have increased double percentwise because of that," Dr. Boh said.

* * *

This week in dermatology news:

  1. Cutaneous clues linked to COVID-19 coagulation risk:
    Research letter:
    Skin manifestations of COVID-19:
  2. Study highlights potential advantages of tape strips over biopsy:
    Original source:
  3. Botulinum toxin associated with antidepressant effects across indications, injection sites:
    Original source:

* * *

Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia)

Guests: Erin Boh, MD, PhD (Tulane University, New Orleans); Dirk M. Elston, MD (Medical University of South Carolina, Charleston)

Disclosures: Dr. Heath, Dr. Boh, and Dr. Elston report no conflicts of interest.

Show notes by: Alicia Sonners, Melissa Sears

* * *

You can find more of our podcasts at

Email the show:

Interact with us on Twitter: @MDedgeDerm

Podcast Participants

Vincent A. DeLeo, MD
Vincent A. DeLeo, MD, is from the Keck School of Medicine of the University of Southern California, Los Angeles, and the Icahn School of Medicine at Mount Sinai, New York, New York. He also is the editor in chief of Cutis and the author of more than 200 publications. He is a leading expert on contact dermatitis, sunscreens, and photosensitivity. Dr. DeLeo is a consultant for Estée Lauder.